Anti-inflammatory Drugs Market By Type, Form, Product and Application - Global Industry Analysis And Forecast To 2027
Published On : December 2018 Pages : 130 Category: Pharmaceuticals Report Code : HC122193
Anti-inflammatory Drugs Market By Type (Prescription Medications and Over-The-Counter); Form (Delayed-Release Tablet, Regular Tablet, Paste, Injection, Liquid and Topical Cream); Product (COX-2 Inhibitors, Ibuprofen, Aspirin, Naproxen and Other) and Application (Chronic Arthritis, Skin Rashes and Other) - Global Industry Analysis And Forecast To 2027
Industry Outlook
The substance or treatment that deals with inflammation or swelling reduction is referred to as Anti-inflammatory property. Half of Anti-inflammatory Drugs consist of painkillers, to give morphine-like effect to block the pain signally the brain caused by inflammation. Anti-inflammatory Drugs is growing due to; rising demand for Anti-inflammatory biologics that are more effective, targeted and have fewer side effects, government strategies to spread knowledge and drive population towards using there drugs, etc. Therefore, the Anti-inflammatory Drugs Market is anticipated to expand and has tremendous scope during the forecast period. The global Anti-inflammatory Drugs Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
The global Anti-inflammatory Drugs Market is based on segment, by Type the market is segmented into Prescription Medications and Over-The-Counter; by Form the market is segmented into Delayed-Release Tablet, Regular Tablet, Paste, Injection, Liquid and Topical Cream; by Product the market is segmented into COX-2 Inhibitors, Ibuprofen, Aspirin, Naproxen and Other; and by Application the market is segmented into Chronic Arthritis, Skin Rashes and Other.
- Anti-inflammatory Drugs Market, By Type
- Prescription Medications
- Over-The-Counter
- Anti-inflammatory Drugs Market, By Form
- Delayed-Release Tablet
- Regular Tablet
- Paste
- Injection
- Liquid
- Topical Cream
- Anti-inflammatory Drugs Market, By Product
- COX-2 Inhibitors
- Ibuprofen
- Aspirin
- Naproxen
- Other
- Anti-inflammatory Drugs Market, By Application
- Chronic Arthritis
- Skin Rashes
- Other
Regional Insights
On a global front, the Anti-inflammatory Drugs Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA).
Anti-inflammatory Drugs Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The leading players in the market are Kopran Ltd., Roche, Novacap, Sanofi, Abbott Laboratories, Bayer, Johnson & Johnson, Amgen, Merck & Co., Eli Lilly, Pfizer, Novartis and Amgen. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Kopran Ltd.
- Roche
- Novacap
- Sanofi
- Abbott Laboratories
- Bayer
- Johnson & Johnson
- Amgen
- Merck & Co.
- Eli Lilly
- Pfizer
- Novartis
- Amgen
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Anti-inflammatory Drugs Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Prescription Medications
o Over-The-Counter
o Anti-inflammatory Drugs Market, By Form, Estimates and Forecast, 2017-2027 ($Million)
o Delayed-Release Tablet
o Regular Tablet
o Paste
o Injection
o Liquid
o Topical Cream
o Anti-inflammatory Drugs Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o COX-2 Inhibitors
o Ibuprofen
o Aspirin
o Naproxen
o Other
o Anti-inflammatory Drugs Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Chronic Arthritis
o Skin Rashes
o Other
o Anti-inflammatory Drugs Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Anti-inflammatory Drugs Market, By Country
o U.S. Anti-inflammatory Drugs Market
o Canada Anti-inflammatory Drugs Market
o Mexico Anti-inflammatory Drugs Market
o Europe
§ Europe Anti-inflammatory Drugs Market, By Country
o Germany Anti-inflammatory Drugs Market
o UK Anti-inflammatory Drugs Market
o France Anti-inflammatory Drugs Market
o Russia Anti-inflammatory Drugs Market
o Italy Anti-inflammatory Drugs Market
o Rest of Europe Anti-inflammatory Drugs Market
o Asia-Pacific
§ Asia-Pacific Anti-inflammatory Drugs Market, By Country
o China Anti-inflammatory Drugs Market
o Japan Anti-inflammatory Drugs Market
o South Korea Anti-inflammatory Drugs Market
o India Anti-inflammatory Drugs Market
o Southeast Asia Anti-inflammatory Drugs Market
o Rest of Asia-Pacific Anti-inflammatory Drugs Market
o South America
§ South America Anti-inflammatory Drugs Market, By Country
o Brazil Anti-inflammatory Drugs Market
o Argentina Anti-inflammatory Drugs Market
o Columbia Anti-inflammatory Drugs Market
o Rest of South America Anti-inflammatory Drugs Market
o Middle East and Africa
§ Middle East and Africa Anti-inflammatory Drugs Market, By Country
o Saudi Arabia Anti-inflammatory Drugs Market
o UAE Anti-inflammatory Drugs Market
o Egypt Anti-inflammatory Drugs Market
o Nigeria Anti-inflammatory Drugs Market
o South Africa Anti-inflammatory Drugs Market
o Rest of MEA Anti-inflammatory Drugs Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Anti-inflammatory Drugs Market, By Type
5.1. Introduction
5.2. Global Anti-inflammatory Drugs Revenue and Market Share by Type (2017-2027)
5.2.1. Global Anti-inflammatory Drugs Revenue and Revenue Share by Type (2017-2027)
5.3. Prescription Medications
5.3.1. Global Prescription Medications Revenue and Growth Rate (2017-2027)
5.4. Over-The-Counter
5.4.1. Global Over-The-Counter Revenue and Growth Rate (2017-2027)
6. Anti-inflammatory Drugs Market, By Form
6.1. Introduction
6.2. Global Anti-inflammatory Drugs Revenue and Market Share by Form (2017-2027)
6.2.1. Global Anti-inflammatory Drugs Revenue and Revenue Share by Form (2017-2027)
6.3. Delayed-Release Tablet
6.3.1. Global Delayed-Release Tablet Revenue and Growth Rate (2017-2027)
6.4. Regular Tablet
6.4.1. Global Regular Tablet Revenue and Growth Rate (2017-2027)
6.5. Paste
6.5.1. Global Paste Revenue and Growth Rate (2017-2027)
6.6. Injection
6.6.1. Global Injection Revenue and Growth Rate (2017-2027)
6.7. Liquid
6.7.1. Global Liquid Revenue and Growth Rate (2017-2027)
6.8. Topical Cream
6.8.1. Global Topical Cream Revenue and Growth Rate (2017-2027)
7. Anti-inflammatory Drugs Market, By Product
7.1. Introduction
7.2. Global Anti-inflammatory Drugs Revenue and Market Share by Product (2017-2027)
7.2.1. Global Anti-inflammatory Drugs Revenue and Revenue Share by Product (2017-2027)
7.3. COX-2 Inhibitors
7.3.1. Global COX-2 Inhibitors Revenue and Growth Rate (2017-2027)
7.4. Ibuprofen
7.4.1. Global Ibuprofen Revenue and Growth Rate (2017-2027)
7.5. Aspirin
7.5.1. Global Aspirin Revenue and Growth Rate (2017-2027)
7.6. Naproxen
7.6.1. Global Naproxen Revenue and Growth Rate (2017-2027)
7.7. Other
7.7.1. Global Other Revenue and Growth Rate (2017-2027)
8. Anti-inflammatory Drugs Market, By Application
8.1. Introduction
8.2. Global Anti-inflammatory Drugs Revenue and Market Share by Application (2017-2027)
8.2.1. Global Anti-inflammatory Drugs Revenue and Revenue Share by Application (2017-2027)
8.3. Chronic Arthritis
8.3.1. Global Chronic Arthritis Revenue and Growth Rate (2017-2027)
8.4. Skin Rashes
8.4.1. Global Skin Rashes Revenue and Growth Rate (2017-2027)
8.5. Other
8.5.1. Global Other Revenue and Growth Rate (2017-2027)
9. Anti-inflammatory Drugs Market, By Region
9.1. Introduction
9.2. Global Anti-inflammatory Drugs Revenue and Market Share by Regions
9.2.1. Global Anti-inflammatory Drugs Revenue by Regions (2017-2027)
9.3. North America Anti-inflammatory Drugs by Countries
9.3.1. North America Anti-inflammatory Drugs Revenue and Growth Rate (2017-2027)
9.3.2. North America Anti-inflammatory Drugs Revenue (Million USD) by Countries (2017-2027)
9.3.3. United States
9.3.3.1. United States Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.3.4. Canada
9.3.4.1. Canada Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.3.5. Mexico
9.3.5.1. Mexico Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.4. Europe Anti-inflammatory Drugs by Countries
9.4.1. Europe Anti-inflammatory Drugs Revenue and Growth Rate (2017-2027)
9.4.2. Europe Anti-inflammatory Drugs Revenue (Million USD) by Countries (2017-2027)
9.4.3. Germany
9.4.3.1. Germany Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.4. France
9.4.4.1. France Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.5. UK
9.4.5.1. UK Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.6. Russia
9.4.6.1. Russia Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.7. Italy
9.4.7.1. Italy Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.8. Rest of Europe
9.4.8.1. Rest of Europe Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.5. Asia-Pacific Anti-inflammatory Drugs by Countries
9.5.1. Asia-Pacific Anti-inflammatory Drugs Revenue and Growth Rate (2017-2027)
9.5.2. Asia-Pacific Anti-inflammatory Drugs Revenue (Million USD) by Countries (2017-2027)
9.5.3. China
9.5.3.1. China Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.4. Japan
9.5.4.1. Japan Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.5. Korea
9.5.5.1. Korea Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.6. India
9.5.6.1. India Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.7. Southeast Asia
9.5.7.1. Southeast Asia Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.8. Rest of Asia-Pacific
9.5.8.1. Rest of Asia-Pacific Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.6. South America Anti-inflammatory Drugs by Countries
9.6.1. South America Anti-inflammatory Drugs Revenue and Growth Rate (2017-2027)
9.6.2. South America Anti-inflammatory Drugs Revenue (Million USD) by Countries (2017-2027)
9.6.3. Brazil
9.6.3.1. Brazil Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.6.4. Argentina
9.6.4.1. Argentina Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.6.5. Columbia
9.6.5.1. Columbia Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.6.6. Rest of South America
9.6.6.1. Rest of South America Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.7. Middle East and Africa Anti-inflammatory Drugs by Countries
9.7.1. Middle East and Africa Anti-inflammatory Drugs Revenue and Growth Rate (2017-2027)
9.7.2. Middle East and Africa Anti-inflammatory Drugs Revenue (Million USD) by Countries (2017-2027)
9.7.3. Saudi Arabia
9.7.3.1. Saudi Arabia Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.4. United Arab Emirates
9.7.4.1. United Arab Emirates Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.5. Egypt
9.7.5.1. Egypt Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.6. Nigeria
9.7.6.1. Nigeria Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.7. South Africa
9.7.7.1. South Africa Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.8. Turkey
9.7.8.1. Turkey Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.9. Rest of Middle East and Africa
9.7.9.1. Rest of Middle East and Africa Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
10. Company Profiles
10.1. Kopran Ltd.
10.1.1. Business Overview
10.1.2. Service Portfolio
10.1.3. Strategic Developments
10.1.4. Revenue and Market Share
10.2. Roche
10.2.1. Business Overview
10.2.2. Service Portfolio
10.2.3. Strategic Developments
10.2.4. Revenue and Market Share
10.3. Novacap
10.3.1. Business Overview
10.3.2. Service Portfolio
10.3.3. Strategic Developments
10.3.4. Revenue and Market Share
10.4. Sanofi
10.4.1. Business Overview
10.4.2. Service Portfolio
10.4.3. Strategic Developments
10.4.4. Revenue and Market Share
10.5. Abbott Laboratories
10.5.1. Business Overview
10.5.2. Service Portfolio
10.5.3. Strategic Developments
10.5.4. Revenue and Market Share
10.6. Bayer
10.6.1. Business Overview
10.6.2. Service Portfolio
10.6.3. Strategic Developments
10.6.4. Revenue and Market Share
10.7. Johnson & Johnson
10.7.1. Business Overview
10.7.2. Service Portfolio
10.7.3. Strategic Developments
10.7.4. Revenue and Market Share
10.8. Amgen
10.8.1. Business Overview
10.8.2. Service Portfolio
10.8.3. Strategic Developments
10.8.4. Revenue and Market Share
10.9. Merck & Co.
10.9.1. Business Overview
10.9.2. Service Portfolio
10.9.3. Strategic Developments
10.9.4. Revenue and Market Share
10.10. Eli Lilly
10.10.1. Business Overview
10.10.2. Service Portfolio
10.10.3. Strategic Developments
10.10.4. Revenue and Market Share
10.11. Pfizer
10.11.1. Business Overview
10.11.2. Service Portfolio
10.11.3. Strategic Developments
10.11.4. Revenue and Market Share
10.12. Novartis
10.12.1. Business Overview
10.12.2. Service Portfolio
10.12.3. Strategic Developments
10.12.4. Revenue and Market Share
10.13. Amgen
10.13.1. Business Overview
10.13.2. Service Portfolio
10.13.3. Strategic Developments
10.13.4. Revenue and Market Share
11. Global Anti-inflammatory Drugs Market Competition, by Manufacturer
11.1. Global Anti-inflammatory Drugs Revenue and Market Share by Manufacturer (2017-2017)
11.2. Global Anti-inflammatory Drugs Price By Region (2017-2017)
11.3. Top 5 Anti-inflammatory Drugs Manufacturer Market Share
11.4. Market Competition Trend
12. Anti-inflammatory Drugs Market Forecast (2017-2027)
12.1. Global Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
12.2. Anti-inflammatory Drugs Market Forecast by Regions (2017-2027)
12.2.1. North America Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.1.1. United States Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.1.2. Canada Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.1.3. Mexico Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.2. Europe Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.2.1. Germany Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.2.2. France Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.2.3. UK Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.2.4. Russia Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.2.5. Italy Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.2.6. Rest of Europe Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.3. Asia-Pacific Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.3.1. China Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.3.2. Japan Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.3.3. Korea Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.3.4. India Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.3.5. Southeast Asia Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.3.6. Rest of Asia-Pacific Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.4. South America Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.4.1. Brazil Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.4.2. Argentina Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.4.3. Columbia Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.4.4. Rest of South America Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.5. Middle East and Africa Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.5.1. Saudi Arabia Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.5.2. United Arab Emirates Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.5.3. Egypt Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.5.4. Nigeria Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.5.5. South Africa Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.5.6. Turkey Anti-inflammatory Drugs Market Forecast (2017-2027)
12.2.5.7. Rest of Middle East and Africa Anti-inflammatory Drugs Market Forecast (2017-2027)
12.3. Anti-inflammatory Drugs Market Forecast by Type (2017-2027)
12.3.1. Anti-inflammatory Drugs Forecast by Type (2017-2027)
12.3.2. Anti-inflammatory Drugs Market Share Forecast by Type (2017-2027)
12.4. Anti-inflammatory Drugs Market Forecast by Form (2017-2027)
12.4.1. Anti-inflammatory Drugs Forecast by Form (2017-2027)
12.4.2. Anti-inflammatory Drugs Market Share Forecast by Form (2017-2027)
12.5. Anti-inflammatory Drugs Market Forecast by Product (2017-2027)
12.5.1. Anti-inflammatory Drugs Forecast by Product (2017-2027)
12.5.2. Anti-inflammatory Drugs Market Share Forecast by Product (2017-2027)
12.6. Anti-inflammatory Drugs Market Forecast by Application (2017-2027)
12.6.1. Anti-inflammatory Drugs Forecast by Application (2017-2027)
12.6.2. Anti-inflammatory Drugs Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Anti-inflammatory Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Anti-inflammatory Drugs Revenue and Revenue Share by Type (2017-2018)
Figure Global Prescription Medications Revenue and Growth Rate (2017-2018)
Figure Global Over-The-Counter Revenue and Growth Rate (2017-2018)
Table Global Anti-inflammatory Drugs Revenue and Revenue Share by Form (2017-2018)
Figure Global Delayed-Release Tablet Revenue and Growth Rate (2017-2018)
Figure Global Regular Tablet Revenue and Growth Rate (2017-2018)
Figure Global Paste Revenue and Growth Rate (2017-2018)
Figure Global Injection Revenue and Growth Rate (2017-2018)
Figure Global Liquid Revenue and Growth Rate (2017-2018)
Figure Global Topical Cream Revenue and Growth Rate (2017-2018)
Table Global Anti-inflammatory Drugs Revenue and Revenue Share by Product (2017-2018)
Figure Global COX-2 Inhibitors Revenue and Growth Rate (2017-2018)
Figure Global Ibuprofen Revenue and Growth Rate (2017-2018)
Figure Global Aspirin Revenue and Growth Rate (2017-2018)
Figure Global Naproxen Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Anti-inflammatory Drugs Revenue and Revenue Share by Application (2017-2018)
Figure Global Chronic Arthritis Revenue and Growth Rate (2017-2018)
Figure Global Skin Rashes Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Anti-inflammatory Drugs Revenue by Regions (2017-2018)
Figure North America Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure North America Anti-inflammatory Drugs Revenue and Growth Rate (2017-2018)
Figure North America Anti-inflammatory Drugs by Countries (2017-2018)
Figure North America Anti-inflammatory Drugs Revenue (Million USD) by Countries (2017-2018)
Figure United States Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure United States Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Canada Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Mexico Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Europe Anti-inflammatory Drugs Revenue and Growth Rate (2017-2018)
Figure Europe Anti-inflammatory Drugs by Countries (2017-2018)
Figure Europe Anti-inflammatory Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Germany Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Germany Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure France Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure UK Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Russia Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Italy Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Rest of Europe Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Asia-Pacific Anti-inflammatory Drugs Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Anti-inflammatory Drugs by Countries (2017-2018)
Figure Asia-Pacific Anti-inflammatory Drugs Revenue (Million USD) by Countries (2017-2018)
Figure China Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure China Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Japan Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Korea Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure India Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Southeast Asia Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure South America Anti-inflammatory Drugs Revenue and Growth Rate (2017-2018)
Figure South America Anti-inflammatory Drugs by Countries (2017-2018)
Figure South America Anti-inflammatory Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Brazil Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Argentina Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Columbia Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Rest of South America Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Middle East and Africa Anti-inflammatory Drugs Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Anti-inflammatory Drugs by Countries (2017-2018)
Figure Middle East and Africa Anti-inflammatory Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Saudi Arabia Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure United Arab Emirates Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Egypt Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Nigeria Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure South Africa Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Turkey Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Anti-inflammatory Drugs Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Table Kopran Ltd. Anti-inflammatory Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Roche Anti-inflammatory Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novacap Anti-inflammatory Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sanofi Anti-inflammatory Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Abbott Laboratories Anti-inflammatory Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bayer Anti-inflammatory Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Johnson & Johnson Anti-inflammatory Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Amgen Anti-inflammatory Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck & Co. Anti-inflammatory Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Eli Lilly Anti-inflammatory Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Anti-inflammatory Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novartis Anti-inflammatory Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Amgen Anti-inflammatory Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Anti-inflammatory Drugs Market Share by Manufacturer
Figure Global Anti-inflammatory Drugs Revenue and Market Share by Manufacturer
Table Global Anti-inflammatory Drugs Price by Region (2017-2017)
Figure Top 5 Anti-inflammatory Drugs Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Anti-inflammatory Drugs Revenue (Millions USD) and Growth Rate (2018-2025)
Table Anti-inflammatory Drugs Market Forecast by Regions (2018-2025)
Figure North America Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure United States Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Canada Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Mexico Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Europe Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Germany Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure France Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure UK Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Russia Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Italy Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Rest of Europe Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Asia-Pacific Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure China Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Japan Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Korea Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure India Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Southeast Asia Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure South America Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Brazil Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Argentina Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Columbia Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Rest of South America Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Middle East and Africa Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Saudi Arabia Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure United Arab Emirates Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Egypt Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Nigeria Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure South Africa Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Turkey Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Anti-inflammatory Drugs Market Forecast (2018-2025)
Figure Global Anti-inflammatory Drugs Forecast by Type (2018-2025)
Figure Global Anti-inflammatory Drugs Market Share Forecast by Type (2018-2025)
Figure Global Anti-inflammatory Drugs Forecast by Type (2018-2025)
Figure Global Anti-inflammatory Drugs Forecast by Form (2018-2025)
Figure Global Anti-inflammatory Drugs Market Share Forecast by Form (2018-2025)
Figure Global Anti-inflammatory Drugs Forecast by Form (2018-2025)
Figure Global Anti-inflammatory Drugs Forecast by Product (2018-2025)
Figure Global Anti-inflammatory Drugs Market Share Forecast by Product (2018-2025)
Figure Global Anti-inflammatory Drugs Forecast by Product (2018-2025)
Figure Global Anti-inflammatory Drugs Forecast by Application (2018-2025)
Figure Global Anti-inflammatory Drugs Market Share Forecast by Application (2018-2025)
Figure Global Anti-inflammatory Drugs Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|